HOME >> MEDICINE >> NEWS
Long-term study demonstrated ADDERALL XR is an effective option to treat adolescents with ADHA

Washington, DC, October 20, 2004 Shire Pharmaceuticals Group plc (NASDAQ: SHPGY, LSE: SHP.L, TSE: SHQ CN) announced today that ADDERALL XR (an extended release, mixed salts amphetamine product) is effective and generally well-tolerated for adolescents with attention-deficit/hyperactivity disorder (ADHD). The short- and long-term study results of the multicenter Phase 3 study were presented today in Washington, DC.

"To date, well-designed, controlled studies of ADHD medications in adolescents have been extremely rare," said lead investigator Stephen Grcevich, M.D., Case Western Reserve University School of Medicine and President and Founder of The Family Center by the Falls, in Chagrin Falls, Ohio. "While the vast majority of safety and efficacy studies with ADHD medications have been conducted in school age children, and more recently, in adult populations, physicians are being asked with increasing frequency to treat adolescents with significant functional impairment associated with ADHD. For this reason, it is critically important to access this long-term data to guide physicians in our treatment of this specific population group."

ADHD is considered the most commonly diagnosed psychiatric disorder in children and adolescents, and affects approximately three to seven percent of all school-age children, or approximately two million children in the U.S. Results from follow-up studies of subjects with ADHD published over the past two decades suggest that up to 80 percent of children diagnosed with ADHD will continue to exhibit symptoms in adolescence and up to 65 percent in adulthood.-

The three main symptoms of ADHD include inattention, hyperactivity and impulsivity. If left untreated, these symptoms may seriously and adversely affect patients as well as their families and friends. Findings from a national survey, "Capturing America's Attention," released earlier this year found that adults with ADHD tend to report lower educ
'"/>

Contact: Marion E. Glick
917-301-4206
Porter Novelli
20-Oct-2004


Page: 1 2 3

Related medicine news :

1. Long-term high consumption of red and processed meat linked with increased risk for colon cancer
2. Long-term data show benefit of DETROL LA as first-line therapy for overactive bladder
3. Long-term benefits for newly diagnosed patients with CML receiving first-line therapy with imatinib
4. Long-term obesity linked to loss of brain tissue in women
5. Long-term study proves ADDERALL XR is a safe and effective option to treat adults with ADHD
6. Long-term use of antibiotics possibly linked with increased risk of breast cancer
7. Long-term follow-up of mortality in patients with community-acquired pneumonia
8. Long-term outcome of epilepsy surgery is favorable for many
9. Long-term ERT in postmenopausal women with Alzheimers may worsen memory
10. Long-term avoidance of milk in children results in poor bone health
11. Long-term effects of tirofiban similar to abciximab in patients having coronary-artery angioplasty

Post Your Comments:
(Date:5/21/2013)... OK (PRWEB) May 21, 2013 Representatives with ... been such a success that the company has achieved its ... plan from day one was to move Hammerhead Bicycles from ... Spokesman and President Scott Robertson. , Robertson explained that the ... and continue to exclusively focus on all things 29er and ...
(Date:5/21/2013)... TheBeautyPlace.com helps brides to breathe a ... Big Day Kit including all the essentials a glowing ... on their Wedding Day. , TheBeautyPlace.com features Wedding Day ... their Wedding Day. Flowers blooming and warmer weather indicates ... season. From Memorial Day to October, brides to be ...
(Date:5/21/2013)... May 2013 EMBO announced today that 52 outstanding ... its membership. Forty-three of the researchers reside in Europe ... of nine Associate Members from Canada, China, India, Japan ... around 1600 life scientists. , "Our members are the ... Director Maria Leptin said. "We have been building our ...
(Date:5/21/2013)... May 21, 2013 Healthcare industry leaders, ... the premier “Start Me Up” Emerging Healthcare Technology Conference, ... in Madison, Wisconsin. This new event is part ... gathering of national healthcare leaders being held June 10-12 ... University of Wisconsin. , Funding for healthcare information technology ...
(Date:5/21/2013)... A plastic surgery Internet marketing ... surgery SEO services following an Internet survey. , ... the “Best Plastic Surgery SEO Services”. , Sources ... predictable. Well-known in the plastic surgery Internet marketing ... any other selection based on superior client results. ...
Breaking Medicine News(10 mins):Health News:Hammerhead Bicycles Now a Standalone Brand 2Health News:TheBeautyPlace.com Previews their Emergency Big Day Kit to Get Brides Ready For this Upcoming Wedding Season 2Health News:TheBeautyPlace.com Previews their Emergency Big Day Kit to Get Brides Ready For this Upcoming Wedding Season 3Health News:EMBO announces 52 new members for 2013 2Health News:“Start Me Up" Healthcare Conference: Where Healthcare CIOs, Entrepreneurs and Investors Meet 2Health News:JD Media Surge's CosmeticSurgeonsOnline.com Voted #1 Source for Plastic Surgery SEO 2
(Date:5/21/2013)... , May 21, 2013  Lehigh Valley Health Network ... TM devices, adding to its existing arsenal of ... taking up residence within the network, LVHN is now ... to proactively combat superbugs and provide the best possible ... Room Ultraviolet Disinfector, TRU-D – the signature product of ...
(Date:5/21/2013)... SUNNYVALE, Calif. , May 21, 2013 /PRNewswire/ ... ), announced today the publication of study results ... the CyberKnife® Robotic Radiosurgery System, the most widely ... (SBRT). The study followed 304 patients for a ... years post-treatment and found that 97 percent of ...
(Date:5/21/2013)... 21, 2013  Janssen R&D Ireland (Janssen) today ... global Phase 3 PROMISE study demonstrating that use ... to sustained virologic response 12 weeks after the ... treatment-experienced genotype 1 chronic hepatitis C adult patients ... liver fibrosis, when administered once daily with pegylated ...
Breaking Medicine Technology:Lehigh Valley Expands Fleet of Superbug-Slaying Robots 2Lehigh Valley Expands Fleet of Superbug-Slaying Robots 3New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 2Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 4Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 5Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 6Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 7
Cached News: